These cells are associated with a reduction in the adaptative immune response to tumor MUC1 by lowering the production of specific antibodies and reducing the activation and proliferation of tumor‐specific T cells while stimulating Treg development.29 This evidence concerns the gene MUC1 and neoplasm.